Cargando…
Diminished gray matter density mediates chemotherapy dosage-related cognitive impairment in breast cancer patients
To investigate chemotherapy dosage-related cognitive impairment and its neural mechanisms in breast cancer (BC) patients. Twenty-eight breast cancer patients after each chemotherapy cycle and matched 29 healthy control subjects underwent structural magnetic resonance imaging. Voxel-based morphometry...
Autores principales: | Li, Xiu, Chen, Haijun, Lv, Yue, Chao, Herta H., Gong, Liang, Li, Chiang-Shan R., Cheng, Huaidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138678/ https://www.ncbi.nlm.nih.gov/pubmed/30218006 http://dx.doi.org/10.1038/s41598-018-32257-w |
Ejemplares similares
-
Gray matter networks and cognitive impairment in multiple
sclerosis
por: Rimkus, Carolina M, et al.
Publicado: (2018) -
Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression
por: Li, Wen, et al.
Publicado: (2020) -
Gray Matters in Multiple Sclerosis: Cognitive Impairment and Structural MRI
por: Messina, Silvia, et al.
Publicado: (2014) -
Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer
por: Chen, Bihong T., et al.
Publicado: (2018) -
Dissociating regional gray matter density and gray matter volume in autism spectrum condition
por: Yankowitz, Lisa D., et al.
Publicado: (2021)